This brand name is authorized in Japan, Mexico
The drug BENECID contains one active pharmaceutical ingredient (API):
|
1
Probenecid
UNII PO572Z7917 - PROBENECID
|
|
Probenecid is a uricosuric and renal tubular blocking agent. It inhibits the tubular reabsorption of urate, thus increasing the urinary excretion of uric acid and decreasing serum urate levels. Effective uricosuria reduces the miscible urate pool, retards urate deposition, and promotes resorption of urate deposits. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M04AB01 | Probenecid | M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AB Preparations increasing uric acid excretion |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3942001F1040 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 40921 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
